About Biomed Industries
Biomed Industries is a company based in San Jose (United States) founded in 2020. It operates as a B2B. Biomed Industries has completed 1 acquisition, including MedAware Systems. Biomed Industries offers products and services including NA-704, NA-831, NA-901, NA-921 (Bionetide), and NA-931 (Bioglutide). Biomed Industries operates in a competitive market with competitors including T3D Therapeutics, Alzheon, Longeveron, Alchemab and Cerecin, among others.
- Headquarter San Jose, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biomed Industries, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomed Industries
Biomed Industries offers a comprehensive portfolio of products and services, including NA-704, NA-831, NA-901, NA-921 (Bionetide), and NA-931 (Bioglutide).
Treats Amyotrophic Lateral Sclerosis by stimulating neurogenesis.
Targets Alzheimer's disease with neuroprotection and neurogenesis.
Addresses Major Depressive Disorder with a safe profile.
Treats Rett Syndrome by crossing the blood-brain barrier.
Manages diabetes obesity via receptor agonism for weight loss.
Handles liver diseases like MASH by regulating IGF-1 function.
Delivers drugs intravenously with FDA approval for home use.
People of Biomed Industries
Unlock access to complete
Unlock access to complete
Funding Insights of Biomed Industries
Detailed funding history for Biomed Industries
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biomed Industries
Biomed Industries has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MedAware Systems.
Investment portfolio details for Biomed Industries
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Scientific-Data-as-a-Service for healthcare providers
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Biomed Industries
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Biomed Industries
Detailed financials for Biomed Industries
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomed Industries Comparisons
Peer comparison for Biomed Industries
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biomed Industries
Biomed Industries operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as T3D Therapeutics, Alzheon, Longeveron, Alchemab and Cerecin, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for neurodegenerative diseases, including Alzheimer's, are developed.
|
|
| Locked | Locked | Locked |
Oral inhibitors of amyloid aggregation for Alzheimer's treatment are developed.
|
|
| Locked | Locked | Locked |
Cellular therapies for aging-related and life-threatening conditions are developed.
|
|
| Locked | Locked | Locked |
Developer of antibody based therapeutics to treat cancers, neurodegenerative conditions and infectious diseases
|
|
| Locked | Locked | Locked |
Medical foods and drugs for Alzheimer's disease are developed.
|
|
| Locked | Locked | Locked |
Genome-scale drug discovery platform is provided for treating multiple diseases.
|
Detailed competitors of Biomed Industries
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomed Industries
Complete news archive for Biomed Industries
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomed Industries
Biomed Industries was founded in 2020.
Biomed Industries is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Biomed Industries focuses on creating innovative drug therapeutics for unmet needs in areas like neurological diseases, including Alzheimers and ALS, and metabolic disorders such as diabetes and obesity. They utilize AI and machine learning to accelerate drug discovery and development through clinical trials. Based in San Jose, California, the company engages in research partnerships and FDA-approved products like the MICROS infusion system, aiming to improve patient outcomes globally without specific client disclosures.
Biomed Industries's top competitors include Alzheon, Longeveron and Alchemab.
Biomed Industries offers NA-704, NA-831, NA-901, NA-921 (Bionetide), and 3 more products and services.
Biomed Industries has made 1 acquisition, including MedAware Systems.